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ACTH, isoprenaline, forskolin, and dibutyryl cyclic AMP prevented insulin from stimulating adipocyte 
pyruvate dehydrogenase in the presence of adenosine deamiaase. Antagonism was reversed by N6-phenyliso- 
propyladenosine as well as oxytocin. The stimulatory effects of insulin, adenosine and oxytocin on adipocyte 
pyruvate dehydrogenase appear to be through (a) mechanism(s) which is (are) similar or related. 
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1. INTRODUCTION 
The ability of glucagon and catecholamines to 
antagonise the stimulatory effect of insulin on 
glucose transport appears to be adenosine related 
in that it is evident only when endogenously pro- 
duced adenosine is removed with adenosine 
deaminase [1,2]. On the other hand, the greatest 
degree of antagonism to isoprenaline inhibition by 
insulin was observed when insulin was added 
together with adenosine to cells treated with 
isoprenaline 131. The mechanism through which 
adenosine exerts its effects on glucose transport re- 
mains to be determined. It has, however, been sug- 
gested that adenosine inhibited adenylate cyclase 
and consequently reduced cyclic AMP levels and 
protein kinase activity. This is based on the fact 
that the inhibitory effect of catecholamines on 
glucose transport is mimicked by dibutyryl cyclic 
AMP [4]. 
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Adenosine has also been shown to activate 
adipocyte pyruvate dehydrogenase and through (a) 
mechanism(s) thought to be similar or related to 
that of insulin [5]. The present study investigated 
the ability of adenosine to prevent cyclic AMP 
elevating agents from antagonising the stimulatory 
effect of insulin on pyruvate dehydrogenase. The 
effects of oxytocin were also investigated since the 
hormone has also been shown to activate adipocyte 
pyruvate dehydrogenase [6,7] but possibly through 
(a) mechanism(s) separate from that of insulin 
FG'I. 
2. MATERIALS AND METHODS 
Insulin was obtained from Dr R. Chance, Eli 
Lilly Co. (Indianapolis, IN, USA), PIA 
(N6-phenylisopropyladenosine) from Boehringer, 
[I-*4C]pyruvic acid from New England Nuclear 
(Boston, MA, USA), collagenase, adenosine 
deaminase, hormones and other biochemicals were 
from Sigma (USA). 
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Dawley rats (150-170 g). Krebs-Ringer bicar- 
bonate buffer [ll], pH 7.4, containing 2.5 mM 
Ca2’ and 4% (w/v) bovine serum albumin was 
used. Ceils were prepared in the presence of 
adenosine deaminase (2 units/ml) to minimise the 
accumulation of endogenous adenosine and its ef- 
fects. Cells so prepared, apart from having a more 
consistent response to adenosine, did not differ 
from those prepared in the absence of adenosine 
deaminase [121. 
PIA was used instead of adenosine in the ex- 
periments since it has simiiar effects as adenosine 
on pyruvate dehydrogenase and is not metabolized 
by adenosine deaminase [5]. 
Experimental conditions and assay of pyruvate 
dehydrogenase activity were as described [ 131. 
3. RESULTS AND DISCUSSION 
3.1. Bffects of HA 00 untago~~sm between 
insulin and cyclic AMP e~evat~~~ agents on 
pyruvate dehydrogenase activity 
Adenosine has been reported to reverse the an- 
tagonism of catecholamines to insulin-stimulated 
glucose transport in adipocytes [2,4]. Whether 
adenosine had similar effects on the regrtlation of 
pyruvate dehydrogenase was investigated with PIA 
in the presence of adenosine deaminase. The ef- 
fects of PIA on the antagonism of various agents 
known to elevate cyclic AMP levels are shown in 
table 1. ACTH, isoprenaline and forskolin com- 
pletely abolished the stimulatory effect of insulin 
on pyruvate dehydrogenase, whilst dibutyryl cyclic 
AMP reduced the effect to slightly above basal 
levels. In all cases, however, PIA completely 
reversed the antagonism between these agents and 
insulin. 
From the above results, it would appear that the 
mechanism through which these agents exerted 
their effects on pyruvate dehydrogenase activity 
was cyclic AMP-mediated. The effect of adenosine 
could then be through the inhibition of adenylate 
cyclase and consequent reduction in cyclic AMP 
levels and protein kinase activity. On the other 
hand, the involvement of Ca” mobilization has 
been proposed by Wallace et al. 1141 as a result of 
their study on the inter-relationship between 
adenosine, glucagon and insulin effects on the 
plasma membrane cyclic AMP phosphodiesterase 
in hepatocytes. In the liver, there are no inhibitory 
Table 1 
PIA reverses antagonism between insulin and cyclic 
AMP elevating agents 
PDH activity 
(nmoilmin 
per mg of 
protein) 
Basal 
Insulin (100 jdU/ml) 
ACTH (2 mU/mI) e insulin 
ACTH + insulin + PIAa (1OgM) 
~sopr~naline (1 ,&Q f ins&n 
isoprenahne -I- insulin + PlA 
Forskolin (1 FM) -+ insulin 
Forskolin + insulin + PIA 
DcAMPb (1 mM) + insulin 
DcAMP c insulin + PIA 
a ~-pheny~isopropyladenosine 
’ Dibutyry~ cyclic AMP 
6.56 + 0.25 
9.72 1 0.16 
7.12 it 0.29 
10.01 i 0.35 
7.28 f 0.40 
9.79 f 0.34 
6.39 +- 0.17 
9.91 * 0.14 
7.91 Ltr. 0.30* 
9.89 _+ 0.35 
Adipocytes were incubated in Krebs-Ringer bicarbonate 
buffer, pW 7.4, for IO min in the presence of adenosine 
deaminase (I unit/ml) and the agents indicated in the 
table. Results are means I SE (n = 6): * p < 0.02 vs 
basal level 
R-site receptors coupled to adenylate cyclase ac- 
tivity [ 151 and desensitization and the blockade of 
insulin effects by glucagon are therefore not cyclic 
AMP-mediated [ 141. 
3.2, Effects of oxytocin on antagonism between 
insulin and cyclic AMP elevating agents on 
py~~vate de~ydroge~ase activity 
Oxytocin, like adenosine, has been reported to 
stimulate pyruvate dehydrogenase in adipocytes 
[5-7f. it has been suggested that its effect could 
probably be through (a) mechanism(s) in common 
with that of insulin [6]. Other studies, however, 
suggest hat insulin-like effects of oxytocin in the 
fat cell could be through independent systems [8,9] 
with the possible involvement of calcium [8]. If ox- 
ytocin stimulation of pyruvate dehydrogenase is 
through a system common to that of insulin [6] as 
is the case with adenosine, there should be a rela- 
tionship between its mode of action and that of 
adenosine. Thus oxytocin should also be able to 
reverse the antagonism between cyclic AMP 
elevating agents and insulin activation of pyruvate 
420 
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dehydrogenase. This was indeed found to be the 
case as shown by the results in table 2. It should be 
noted, however, that in this series of experiments, 
the cyclic AMP elevating agents, other than for- 
skolin, did not completely abolish the stimulation 
by insulin to basal levels of pyruvate 
dehydrogenase activity. The reason for this could 
not be established. 
3.3. Effects of HA on the antagonism between 
oxytocin and cyclic AMP elevating agents on 
~y~vate dehydrogenase activity 
The effects of oxytocin on pyruvate 
dehydrogenase activity in adipocytes in the 
presence of cyclic AMP elevating agents were in- 
vestigated since the role of cyclic AMP in oxytocin 
action is still controversial [9]. Results in table 3 
show that oxytocin-stimulated pyruvate dehydro- 
genase activity was abolished by agents known to 
elevate cyclic AMP. This antagonism between ox- 
ytocin and ACTH or forskolin was completely 
reversed by PIA. This was, however, not the case 
with dibutyryl cyclic AMP where a small residual 
antagonism rem~ned. The difference observed 
between this agent and the others in their an- 
tagonism to oxytocin and insulin effects (tables 
1,2) could be due to the difference in its mode of 
Table 2 
Oxytocin reverse antagonism between insulin and cyclic 
AMP elevating agents 
PDH activity 
{nmol/min 
per mg of 
protein) 
Basal 3.34 f 0.02 
Insulin (100 AU/ml) 5.26 t 0.09 
ACTH (2 mu/ml) + insulin 4.20 f 0.25 
ACTH + insulin + oxytocin (1 PM) 5.17 + 0.10* 
Isoprenafine (1 PM) + insulin 4.26 -t 0.17 
Isoprenafine + insulin + oxytocin 5.23 + 0.02** 
Forskolin (1 FM) + insulin 3.61 f 0.03 
Forskolin + insulin + oxytocin 4.20 z!z 0.03** 
DcAMP (1 mM) + insulin 4.53 + 0.02 
DcAMP + insulin + oxytocin 5.24 + 0.06* 
Experimental conditions similar to those for table 1. 
Results are means 2 SE (n = 6): * p < 0.01, ** p < 0.001 
vs corresponding level without oxytocin 
action in elevating cyclic AMP levels in the 
adipocyte. Dibutyryl cyclic AMP is believed to 
raise the cyclic AMP level by competitive inhibi- 
tion of the cyclic AMP phosphodiesterase [16]. 
3.4. The inter-relationship of the effects of 
adenosine and oxytocin with that of insulin 
on pyruvate dehydrogenase 
The effects of oxytocin and insulin obtained in 
the presence of maximally effective concentrations 
of both agents were not additive for either glucose 
oxidation or lipogenesis [17]. Whether this was 
also the case for the activation of pyruvate 
dehydrogenase was investigated. 
Results in table 4 show that neither oxytocin or 
PIA enhanced the effect of insulin at its optimal 
concentration of 100 punits/ml. Thus there may be 
a common mechanism through which adenosine, 
oxytocin and insulin exert their effects on 
adipocyte pyruvate dehydrogenase. In the present 
study, a near maximal concentration of IOpM 
adenosine (as determined in [3]) was used for the 
experiments. This was to avoid the inhibitory ef- 
fect which sometimes occurred when maximal con- 
centrations of adenosine were used in the presence 
of optimal concentrations of insulin. The concen- 
tration of oxytocin could also have been submax- 
Table 3 
PIA reverse antagonism between oxytocin and cyclic 
AMP elevating agents 
PDH activity 
(nmoI/min 
per mg of 
protein) 
Basal 5.17 f 0.28 
Oxytocin (1 /IM) 7.31 rt 0.32 
Oxytocin c PIA (10 pM) 7.88 * 0.38 
ACTH (2 mu/ml) + oxytocin 5.34 ri: 0.33 
ACTH + oxytocin + PIA 7.72 f 0.47** 
Forskolin (1 ,QM) + oxytocin 4.86 rt 0.06 
Forskolin + oxytocin + PIA 7.63 f 0.38** 
DcAMP (1 mM) + oxytocin 4.52 + 0.05 
DcAMP + oxytocint + PIA 6.65 + 0.23: 
Experimental conditions similar to those for table 1. 
Results are means & SE (n = 6): ** p < 0.01 or better 
vs corresponding level without PIA, * p < 0.05 vs level 
without DcAMP 
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Table 4 
~nt~r”re~at~onship between insulin, PIA and oxgtocin in 
the st~mula#~on of adipocyte p~ruva~e deh~drogen~e 
PRH activity 
fnmol/min 
per mg of 
protein) 
Basal 5.73 + 0.43 
Insulin (100 &/ml) 9,12 2 0.61 
PIA (10pM) 7,54 + 0.46 
Oxytocin (1 gM) 1.32 2 0.36 
Insulin + PEA 9.56 r4 0.64 
Insulin + oxytocin l&O4 f 0.69 
PIA -e ~xytocin 9.35 f 0.48% 
insulin + PfA 4 oxytocin 10.23 t 0.71 
Experimental conditions similar to those of table 1. 
Results are means rt SE {n = 6): * p < 0.05 vs level with 
PIA alone, ** p < 0.02 vs level with oxytocin alone 
imal, as its dose response for rnaxjrn~~ effects was 
found to vary between 0.1 and 10 PM (not shown). 
This could probably account for the effect of 
adenosine being enhanced by oxytocin, and vice 
versa. It should be noted, however, that the effects 
of these 2 agents added together did not exceed the 
maximum effects of insulin, 
Eu conciusion, the ability to reverse the an- 
tagonism between cychc AMP elevating agents and 
insulin effects is not limited ta adenasine action 
alane. The present study shows that oxytocin has 
similar properties and the mechanism through 
which these effects are exerted appears to be 
simifar or related. There is no evidence that both 
adeu~siue and oxytocin exerted their effects in- 
dependent of the cycfic AMP system, since an- 
tago~~sm by forskolin and d~butyry~ cycfic AMP 
were effectively reversed. 
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